186 related articles for article (PubMed ID: 2607716)
21. Evaluation of DD23 as a marker for detection of recurrent transitional cell carcinoma of the bladder in patients with a history of bladder cancer.
Gilbert SM; Veltri RW; Sawczuk A; Shabsigh A; Knowles DR; Bright S; O'Dowd GJ; Olsson CA; Benson MC; Sawczuk IS
Urology; 2003 Mar; 61(3):539-43. PubMed ID: 12639642
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic value of voided urine and bladder barbotage cytology in detecting transitional cell carcinoma of the urinary tract.
Konety BR; Metro MJ; Melham MF; Salup RR
Urol Int; 1999; 62(1):26-30. PubMed ID: 10436427
[TBL] [Abstract][Full Text] [Related]
23. Bladder cancer risk assessment with quantitative fluorescence image analysis of tumor markers in exfoliated bladder cells.
Bonner RB; Hemstreet GP; Fradet Y; Rao JY; Min KW; Hurst RE
Cancer; 1993 Oct; 72(8):2461-9. PubMed ID: 8402463
[TBL] [Abstract][Full Text] [Related]
24. DNA flow cytometry and bladder irrigation cytology in detection of bladder carcinoma.
Kumar NU; Dey P; Mondal AK; Singh SK; Vohra H
Diagn Cytopathol; 2001 Mar; 24(3):153-6. PubMed ID: 11241896
[TBL] [Abstract][Full Text] [Related]
25. The predictive value of flow cytometry and urinary cytology in the followup of patients with transitional cell carcinoma of the bladder.
Giella JG; Ring K; Olsson CA; Karp FS; Benson MC
J Urol; 1992 Aug; 148(2 Pt 1):293-6. PubMed ID: 1635121
[TBL] [Abstract][Full Text] [Related]
26. Cytometric investigations of bladder irrigation/washing and voided urine.
Longatto Filho A; Santinelli A; Montironi R
Pathologica; 2001 Apr; 93(2):164-7. PubMed ID: 11428296
[TBL] [Abstract][Full Text] [Related]
27. Image cytometric deoxyribonucleic acid analysis of urine specimens as an adjunct to visual cytology in the detection of urothelial cell carcinoma.
Amberson JB; Laino JP
J Urol; 1993 Jan; 149(1):42-5. PubMed ID: 8417214
[TBL] [Abstract][Full Text] [Related]
28. The performance of the Xpert Bladder Cancer Monitor Test and voided urinary cytology in the follow-up of urinary bladder tumors.
Smrkolj T; Cegovnik Primozic U; Fabjan T; Sterpin S; Osredkar J
Radiol Oncol; 2020 Dec; 55(2):196-202. PubMed ID: 33764701
[TBL] [Abstract][Full Text] [Related]
29. Performance of nuclear matrix protein 22 urine marker and voided urine cytology in the detection of urinary bladder tumors.
Smrkolj T; Mihelič M; Sedlar A; Sterle I; Osredkar J; Sedmak B
Clin Chem Lab Med; 2011 Feb; 49(2):311-6. PubMed ID: 21118051
[TBL] [Abstract][Full Text] [Related]
30. Failure of anticytokeratin 18 antibody to improve flow cytometric detection of bladder cancer.
Konchuba AM; Clements MC; Schellhammer PF; Schlossberg SM; Wright GL
Cancer; 1992 Dec; 70(12):2879-84. PubMed ID: 1280531
[TBL] [Abstract][Full Text] [Related]
31. Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity.
Kavaler E; Landman J; Chang Y; Droller MJ; Liu BC
Cancer; 1998 Feb; 82(4):708-14. PubMed ID: 9477104
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic predictive value of the Bladder EpiCheck test in the follow-up of patients with non-muscle-invasive bladder cancer.
Trenti E; D'Elia C; Mian C; Schwienbacher C; Hanspeter E; Pycha A; Kafka M; Degener S; Danuser H; Roth S; Pycha A
Cancer Cytopathol; 2019 Jul; 127(7):465-469. PubMed ID: 31154670
[TBL] [Abstract][Full Text] [Related]
33. The relative value of cytometry and cytology in the management of bladder cancer: the Memorial Sloan-Kettering Cancer Center experience.
Badalament RA; Fair WR; Whitmore WF; Melamed MR
Semin Urol; 1988 Feb; 6(1):22-30. PubMed ID: 3291043
[TBL] [Abstract][Full Text] [Related]
34. Interphase cytogenetics as an adjunct in the cytodiagnosis of urinary bladder carcinoma. A comparative study of cytology, flow cytometry and interphase cytogenetics in bladder washes.
Cajulis RS; Haines GK; Frias-Hidvegi D; McVary K
Anal Quant Cytol Histol; 1994 Feb; 16(1):1-10. PubMed ID: 8011035
[TBL] [Abstract][Full Text] [Related]
35. Urinary cytology for the detection of urothelial carcinoma of the bladder--a flawed adjunct to cystoscopy?
Bolenz C; West AM; Ortiz N; Kabbani W; Lotan Y
Urol Oncol; 2013 Apr; 31(3):366-71. PubMed ID: 21414815
[TBL] [Abstract][Full Text] [Related]
36. The role of urinary cytology for detection of bladder cancer.
Planz B; Jochims E; Deix T; Caspers HP; Jakse G; Boecking A
Eur J Surg Oncol; 2005 Apr; 31(3):304-8. PubMed ID: 15780568
[TBL] [Abstract][Full Text] [Related]
37. Sensitivity of urine cytology in detecting high-grade urothelial carcinoma in patients with neoplastic urinary bladder diverticula: A major cancer center experience.
Alhamar M; Al-Ahmadie HA; Feratovic R; Lin O
Cancer Cytopathol; 2024 Mar; 132(3):144-151. PubMed ID: 38054371
[TBL] [Abstract][Full Text] [Related]
38. Ancillary techniques in the followup of transitional cell carcinoma: a comparison of cytology, histology and deoxyribonucleic acid image analysis cytometry in 91 patients.
Mora LB; Nicosia SV; Pow-Sang JM; Ku NK; Diaz JI; Lockhart J; Einstein A
J Urol; 1996 Jul; 156(1):49-54; discussion 54-5. PubMed ID: 8648836
[TBL] [Abstract][Full Text] [Related]
39. Bladder transitional cell carcinomas: a comparative study of washing and tumor bioptic samples by DNA flow cytometry and FISH analyses.
Eleuteri P; Grollino MG; Pomponi D; Guaglianone S; Gallucci M; De Vita R
Eur Urol; 2000 Mar; 37(3):275-80. PubMed ID: 10720852
[TBL] [Abstract][Full Text] [Related]
40. Detection of bladder tumors by immunostaining of the Lewis X antigen in cells from voided urine.
Golijanin D; Sherman Y; Shapiro A; Pode D
Urology; 1995 Aug; 46(2):173-7. PubMed ID: 7624989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]